NASDAQ:FOLD
Amicus Therapeutics Stock News
$10.28
+0.110 (+1.08%)
At Close: Apr 26, 2024
Amicus Therapeutics, Inc. (NASDAQ:FOLD) COO Bradley L. Campbell Sells 2,500 Shares
08:46am, Tuesday, 10'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) COO Bradley L. Campbell sold 2,500 shares of Amicus Therapeutics stock in a transaction on Thursday, March 5th. The shares were sold at an average price of $10.
Cowen & Co. Maintains a Buy Rating on Amicus (FOLD)
11:56pm, Monday, 09'th Mar 2020
In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Amicus (FOLD), with a price target of $31.00. The company's shares
Cowen & Co. Maintains a Buy Rating on Amicus (FOLD)
11:56pm, Monday, 09'th Mar 2020
In a report released today, Ritu Baral from Cowen & Co. maintained a Buy rating on Amicus (FOLD – Research
Fmr LLC Sells 978,347 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD)
08:44am, Monday, 09'th Mar 2020
Fmr LLC trimmed its holdings in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) by 34.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
FY2020 Earnings Estimate for Amicus Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:FOLD)
06:42am, Monday, 09'th Mar 2020
Amicus Therapeutics, Inc. (NASDAQ:FOLD) – Equities research analysts at Cantor Fitzgerald decreased their FY2020 EPS estimates for Amicus Therapeutics in a research note issued on Thursday, March 5t
